Literature DB >> 31356383

Breast Magnetic Resonance Spectroscopy at 3 T in Biopsy-Proven Breast Cancers: Does Choline Peak Correlate With Prognostic Factors?

Francesca Galati1, Maria Laura Luciani, Claudia Caramanico, Giuliana Moffa, Carlo Catalano, Federica Pediconi.   

Abstract

OBJECTIVES: The role of functional techniques, such as magnetic resonance spectroscopy (H-MRS), as noninvasive tools to increase breast MR imaging reliability has been widely investigated during the last 2 decades. Considering the growing interest in tumor biology and its influence on functional parameters, the aim of this study was to investigate the relationship between H-MRS parameters and breast cancer biomarkers and to evaluate whether the results of H-MRS at 3 T can correlate with established breast cancer prognostic factors in our clinical experience.
MATERIALS AND METHODS: One hundred two patients with biopsy-proven breast cancer underwent 3 T breast MR imaging. Single-voxel H-MRS was performed after the T1-weighted sequence, using a PRESS water-suppressed sequence (BREASE). Data were collected from a single rectangular volume of interest that encompassed the lesion. Magnetic resonance images and spectra of 102 Breast Imaging Reporting and Data System 6 lesions were prospectively evaluated by 2 radiologists in consensus. H-MRS results were considered positive if the choline peak signal-to-noise ratio was 2 or higher. H-MRS findings were then compared with morphological features and to histological findings, such as lesion size, nuclear grade, Ki-67, hormone receptor status, and Her2 expression.
RESULTS: Elevated levels of total choline were detectable in 68/102 cases (66.67%) and undetectable in 34/102 (33.33%). A statistically significant association between the presence of choline peak and higher tumor grading (P < 0.0001), greater Ki-67 value (P < 0.0001), and larger lesion size (P < 0.0001) was found. No statistically significant associations were observed between choline peak and the luminal subgroups, even if higher levels of choline were more frequent in nonluminal A lesions.
CONCLUSIONS: Our study confirms that 3 T breast H-MRS can be a valid additional tool to obtain further information about breast cancer biology and to predict tumor aggressiveness, because the detection of elevated levels of total choline in the spectrum is associated with a biologically aggressive breast cancer phenotype (large dimensions, grade 3, high values of Ki-67). Our results need to be validated in standardized larger-scale studies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31356383     DOI: 10.1097/RLI.0000000000000597

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  7 in total

1.  Breast cancer screening programs: does one risk fit all?

Authors:  Federica Pediconi; Francesca Galati
Journal:  Quant Imaging Med Surg       Date:  2020-04

2.  Alter between gut bacteria and blood metabolites and the anti-tumor effects of Faecalibacterium prausnitzii in breast cancer.

Authors:  Ji Ma; Lingqi Sun; Ying Liu; Hui Ren; Yali Shen; Feng Bi; Tao Zhang; Xin Wang
Journal:  BMC Microbiol       Date:  2020-04-09       Impact factor: 3.605

Review 3.  Breast Cancer Subtypes and Quantitative Magnetic Resonance Imaging: A Systemic Review.

Authors:  Toshiki Kazama; Taro Takahara; Jun Hashimoto
Journal:  Life (Basel)       Date:  2022-03-28

Review 4.  MRI as a biomarker for breast cancer diagnosis and prognosis.

Authors:  Francesca Galati; Veronica Rizzo; Rubina Manuela Trimboli; Endi Kripa; Roberto Maroncelli; Federica Pediconi
Journal:  BJR Open       Date:  2022-05-26

5.  Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?

Authors:  Francesca Galati; Veronica Rizzo; Giuliana Moffa; Claudia Caramanico; Endi Kripa; Bruna Cerbelli; Giulia D'Amati; Federica Pediconi
Journal:  Eur Radiol Exp       Date:  2022-08-08

6.  The contribution of the 1H-MRS lipid signal to cervical cancer prognosis: a preliminary study.

Authors:  Miriam Dolciami; Rossella Canese; Claudia Testa; Angelina Pernazza; Giusi Santangelo; Innocenza Palaia; Carlo Della Rocca; Carlo Catalano; Lucia Manganaro
Journal:  Eur Radiol Exp       Date:  2022-10-03

7.  Special Issue "Advances in Breast MRI".

Authors:  Francesca Galati; Rubina Manuela Trimboli; Federica Pediconi
Journal:  Diagnostics (Basel)       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.